Gilead Sciences Lab
Oct. 4, 2024
Gilead Sciences Tenant Improvement Laboratory Gilead to stop late-stage study of Covid-19 treatment Gilead Sciences Pricing wars heat up over hepatitis C drugs Gilead Poised to Upend Market With Its First Covid-19 Study Data - Bloomberg Gilead to Buy Kite, Maker of Cancer Treatments, for $11.9 Billion - The New York Times | Gilead Sciences Lab
